BPC-157: what the research actually says

BPC-157 is one of the most-searched peptides online, usually alongside claims about faster recovery from injuries. It's worth separating what the science has actually shown from what the marketing implies, because the gap between the two is unusually wide here.

What BPC-157 is

BPC-157 (short for "Body Protection Compound-157") is a synthetic chain of 15 amino acids. It's a partial sequence derived from a protein found in human gastric juice. It does not exist as a standalone molecule in the body; it's a lab-made fragment that researchers have studied for effects on tissue and healing.

What the evidence shows — and where it stops

The large majority of BPC-157 research is preclinical, meaning it was done in animals (mostly rats) or in cells, not in people. In those studies, researchers have reported effects on the healing of tendons, muscle, gut tissue, and blood vessels. That's the source of its reputation.

The critical caveat: there are essentially no published, controlled human clinical trials establishing that BPC-157 works, is safe, or should be dosed a particular way in people. Results in rodents frequently fail to translate to humans, which is exactly why human trials exist. Until those are run, its benefits in people remain unproven rather than disproven — an important but real distinction.

Regulatory status: not approved, and restricted

BPC-157 is not an FDA-approved drug for any use. In 2023, the FDA placed BPC-157 in the bulk-substances category that it considers to raise significant safety concerns for compounding (often referred to as its Category 2 list), citing insufficient data to evaluate its safety. In practice, that limits licensed compounding pharmacies from preparing it. This is a key reason so much of the BPC-157 sold online carries the "research use only" label — a route we cover on our telehealth vs research-use-only vendors page.

What's actually known about safety

Animal studies have not generally reported major toxicity, and that fact often gets repeated as if it means BPC-157 is "safe." It doesn't. Safety in humans requires human data — on dosing, interactions, purity of the actual product injected, and long-term effects — and that data isn't there. The FDA's action was driven specifically by this absence of safety information, not by evidence of harm. "No proof of harm" and "proof of safety" are not the same thing.

If you're considering it anyway

The responsible path is the same as for any peptide: talk to a licensed clinician rather than self-sourcing from a vendor. A provider can tell you what human evidence does and doesn't exist for your specific goal, and the medical channel is the only one with quality control. Our safest way to try peptides guide walks through how to vet a provider, and are peptides safe covers the category-level risks.